GOLDMAN SACHS GROUP INC - KRONOS BIO INC ownership

KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 95 filers reported holding KRONOS BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KRONOS BIO INC
ValueSharesWeighting
Q3 2023$35,636
-40.5%
27,412
-21.3%
0.00%
Q2 2023$59,899
-79.2%
34,825
-82.3%
0.00%
Q1 2023$287,576
-11.9%
196,970
-2.2%
0.00%
Q4 2022$326,307
-63.9%
201,424
-25.3%
0.00%
Q3 2022$904,000
-40.4%
269,785
-35.3%
0.00%
Q2 2022$1,518,000
+0.1%
417,242
+98.9%
0.00%
Q1 2022$1,517,000
-33.0%
209,825
+26.0%
0.00%
Q4 2021$2,264,000
-7.3%
166,560
+43.0%
0.00%
-100.0%
Q3 2021$2,441,000
+262.2%
116,489
+313.6%
0.00%
Q2 2021$674,000
+24.6%
28,164
+52.4%
0.00%
Q1 2021$541,000
-57.4%
18,480
-56.5%
0.00%
Q4 2020$1,270,00042,5310.00%
Other shareholders
KRONOS BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,765,314$4,037,3585.52%
Omega Fund Management, LLC 3,818,283$5,574,6933.64%
Nextech Invest Ltd. 1,451,537$2,119,2440.88%
Wildcat Capital Management, LLC 1,297,959$1,895,0200.70%
Privium Fund Management (UK) Ltd 292,182$455,8040.36%
CM Management, LLC 180,000$2630.31%
Artal Group S.A. 1,542,954$2,2530.13%
Alphabet Inc. 1,438,232$2,099,8190.12%
Perceptive Advisors 1,752,745$2,558,1310.08%
GSA CAPITAL PARTNERS LLP 406,362$5930.06%
View complete list of KRONOS BIO INC shareholders